ResApp Health (ASX:RAP) has been granted a trading halt by the ASX, pending an update on the company’s partnership with a humanitarian organisation.
ResApp's focus is the development of smartphone applications for the diagnosis and management of respiratory disease.
The halt will remain in place until the opening of trade on Wednesday 10th May 2017, or earlier if an announcement is made to the market.